← back to search

Xiaofei Zhou

St. John Medical Center · CN
Area of research
Immunology · Oncology
Research interest
Research interests include Immune Cell Function and Interaction, Immunotherapy and Immune Responses, CAR-T cell therapy research, and interferon and immune responses.
h-index
37
citations
4,621
works
172
NIH funding
primary concept
Medicine
email

Recent publications

A novel GARP humanized mouse model for efficacy assessment of GARP-targeting therapies
International Immunopharmacology 2024cited by 6position: middledoi
All Roads Lead to Rome: Comparing Nanoparticle‐ and Small Molecule‐Driven Cell Autophagy
Small 2024cited by 6position: firstdoi
Endothelial FIS1 DeSUMOylation Protects Against Hypoxic Pulmonary Hypertension
Circulation Research 2023cited by 42position: firstdoi
Effect of Intravenous Tirofiban vs Placebo Before Endovascular Thrombectomy on Functional Outcomes in Large Vessel Occlusion Stroke
JAMA 2022cited by 191position: middledoi
Dapl1 controls NFATc2 activation to regulate CD8+ T cell exhaustion and responses in chronic infection and cancer
Nature Cell Biology 2022cited by 45position: middledoi
NF-κB-inducing kinase maintains T cell metabolic fitness in antitumor immunity.
2021cited by 93position: contributordoi
Targeting ubiquitin signaling for cancer immunotherapy.
2021cited by 65position: contributordoi
TRAF2 regulates T cell immunity by maintaining a Tpl2-ERK survival signaling axis in effector and memory CD8 T cells.
2021cited by 14position: contributordoi
Author Correction: NF-κB-inducing kinase maintains T cell metabolic fitness in antitumor immunity.
2021cited by 1position: contributordoi
Two-Dimensional Transition Metal Dichalcogenides: Synthesis, Biomedical Applications and Biosafety Evaluation
Frontiers in Bioengineering and Biotechnology 2020cited by 113position: firstdoi
Intestinal Epithelial TBK1 Prevents Differentiation of T-helper 17 Cells and Tumorigenesis in Mice
Gastroenterology 2020cited by 31position: contributordoi
TBKBP1 and TBK1 form a growth factor signalling axis mediating immunosuppression and tumourigenesis.
2019cited by 82position: contributordoi
Remote Induction of Cell Autophagy by 2D MoS<sub>2</sub> Nanosheets via Perturbing Cell Surface Receptors and mTOR Pathway from Outside of Cells
ACS Applied Materials & Interfaces 2019cited by 39position: firstdoi
LncRNAs Expression in Preeclampsia Placenta Reveals the Potential Role of LncRNAs Contributing to Preeclampsia Pathogenesis
PLoS ONE 2013cited by 109position: middledoi
Ubc13 maintains the suppressive function of regulatory T cells and prevents their conversion into effector-like T cells
Nature Immunology 2012cited by 134position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Shao-Cong Sun · Capital Medical University6 papers (2019–2021) · 6 papers (2019–2021)Xiaoping Xie · Shandong Agricultural University4 papers (2020–2021)Lele Zhu · Methodist Hospital3 papers (2021–2021)Jing Wang · Air Force Medical University2 papers (2021–2021)Jae Bum Kim · Bethlehem Area School District2 papers (2021–2021)Bing Yan · Beijing Sport University2 papers (2019–2024)Shao‐Cong Sun · University of Houston2 papers (2012–2022)Xuhong Cheng · University of Houston2 papers (2012–2022)Gaoxing Su · Shandong University2 papers (2019–2024)Meidi Gu · Parker Institute for Cancer Immunotherapy1 papers (2022–2022)Huiying Huang · Leshan Normal University1 papers (2013–2013)Xuefeng Wu · East China Jiaotong University1 papers (2012–2012) · 1 papers (2013–2013)Jianbo Jia · Shandong University1 papers (2019–2019)Ting Chen · Ningbo University1 papers (2023–2023)Chen Wang · Jiangsu University1 papers (2013–2013)Yiran Wang · University of California, San Francisco1 papers (2023–2023)Dong Liu · Nantong University1 papers (2024–2024)Zhi Zhang · Huazhong University of Science and Technology1 papers (2024–2024)